Comorbidities’ Effect on IPF: Pathogenesis and Management

Comorbidities’ Effect on IPF: Pathogenesis and Management

In recent years, there has been a growing recognition within the medical community that idiopathic pulmonary fibrosis (IPF) cannot be effectively managed through a singular focus on the disease itself. Instead, a dual approach is essential, one that not only aims to prolong survival by targeting the...

Full description

Saved in:

Bibliographic Details
Main Authors:	Andrea Salotti, Maria Chianese, Antonio Romallo, Anna De Nes, Darina Angoni, Alessandra Galantino, Maria Chernovsky, Lucrezia Mondini, Francesco Salton, Paola Confalonieri, Rossella Cifaldi, Pietro Geri, Micol Pividori, Giulia Bandini, Michael Hughes, Marco Confalonieri, Marta Maggisano, Barbara Ruaro
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Biomedicines
Subjects:	idiopathic pulmonary fibrosis (IPF) comorbidities pulmonary hypertension cardiovascular disease lung cancer gastroesophageal reflux disease
Online Access:	https://www.mdpi.com/2227-9059/13/6/1362
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis
by: Stefano Kette, et al.
Published: (2025-03-01)

Alveolar Tissue Fiber and Surfactant Effects on Lung Mechanics—Model Development and Validation on ARDS and IPF Patients
by: Jiayao Yuan, et al.
Published: (2021-01-01)

Polypharmacy and potentially inappropriate medication (PIM) use among older veterans with idiopathic pulmonary fibrosis (IPF) – a retrospective cohort study
by: Daniel M. Guidot, et al.
Published: (2025-04-01)

Interaction mechanism between blockchain and IPFS
by: Feng Yang, et al.
Published: (2023-07-01)

Lung transplant bridging strategies in patients with idiopathic pulmonary fibrosis: An SRTR database analysis
by: Yota Suzuki, MD, et al.
Published: (2025-08-01)

Comparing survival outcomes of anti-fibrotic therapy for idiopathic pulmonary fibrosis with and without emphysema: a multi-center real-world study from Taiwan
by: Yu-Hung Fang, et al.
Published: (2025-08-01)

BACP-LRS: Blockchain and IPFS-based Land Record System
by: Insaf Boumezbeur, et al.
Published: (2025-01-01)

Nomogram model using serum Club cell secretory protein 16 to predict prognosis and acute exacerbation in patients with idiopathic pulmonary fibrosis
by: Yaqiong Tian, et al.
Published: (2025-01-01)

Pathogenesis and current status of the treatment of lung cancer associated with idiopathic pulmonary fibrosis
by: Yuanyuan Zhang, et al.
Published: (2025-07-01)

Editorial: Emerging advances in exploiting pulmonary administration for treatment of thoracic diseases
by: Lina Wu, et al.
Published: (2025-04-01)

A bioinformatics approach combined with experimental validation analyzes the efficacy of azithromycin in treating SARS-CoV-2 infection in patients with IPF and COPD
by: Yining Xie, et al.
Published: (2025-03-01)

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland
by: Sebastian Majewski, et al.
Published: (2025-06-01)

Protective effects of N-acetylcysteine against irinotecan – induced pulmonary toxicity in female albino rats
by: Hawrin Burhan Khudhur, et al.
Published: (2024-12-01)

Identification of diagnostic hub genes related to energy metabolism in idiopathic pulmonary fibrosis
by: S. Zhao, et al.
Published: (2025-06-01)

An Elastase Inhibitor ShSPI from Centipede Attenuates Bleomycin-Induced Pulmonary Fibrosis
by: Xi Lian, et al.
Published: (2025-04-01)

Caveolin Scaffolding Domain (CSD) Peptide LTI-2355 Modulates the Phagocytic and Synthetic Activity of Lung-Derived Myeloid Cells in Idiopathic Pulmonary Fibrosis (IPF) and Post-Acute Sequelae of COVID Fibrosis (PASC-F)
by: Brecht Creyns, et al.
Published: (2025-03-01)

Idiopathic Pulmonary Fibrosis, Today and Tomorrow: Certainties and New Therapeutic Horizons
by: Giacomo Giulianelli, et al.
Published: (2025-05-01)

Predictive models and WTAP targeting for idiopathic pulmonary fibrosis (IPF)
by: Guo-Dong Li, et al.
Published: (2025-04-01)

Uridine alleviates the aging of alveolar epithelial cells in idiopathic pulmonary fibrosis through the Keap1-Nrf2 signaling pathway
by: Chenchun Ding, et al.
Published: (2025-07-01)

Ferroptosis in idiopathic pulmonary fibrosis: mechanisms, impact, and therapeutic opportunities
by: Mingjun Yao, et al.
Published: (2025-05-01)

Person-centred health outcomes in the routine care for people with progressive pulmonary fibrosis: the COCOS-IPF project’s European survey on healthcare professionals’ views and practices
by: Vivien Somogyi, et al.
Published: (2025-02-01)

Revised Precapillary Pulmonary Hypertension Criteria and Their Prognostic Value in IPF Transplant Waitlist Survival
by: Zehra Dhanani, et al.
Published: (2025-01-01)

Usual Interstitial Pneumonia Pattern and Mycobacteria Lung Diseases: A Case Series
by: Maria Angela Licata, et al.
Published: (2025-04-01)

Developing an IPF Prognostic Model and Screening for Key Genes Based on Cold Exposure-Related Genes Using Bioinformatics Approaches
by: Peiyao Luo, et al.
Published: (2025-03-01)

The immune mechanisms of acute exacerbations of idiopathic pulmonary fibrosis
by: Tao Chen, et al.
Published: (2024-12-01)

Successful treatment of life-threatening mycobacteriosis using adjunctive gamma-interferon therapy with genetic analysis
by: P. Confalonieri, et al.
Published: (2024-01-01)

Persistent microbial infections and idiopathic pulmonary fibrosis - an insight into non-typeable Haemophilus influenza pathogenesis
by: Anthony Shadid, et al.
Published: (2024-12-01)

PI3K/Akt in IPF: untangling fibrosis and charting therapies
by: Janki Bhatt, et al.
Published: (2025-03-01)

Blood urea nitrogen-to-albumin ratio as a new prognostic indicator of 1-year all-cause mortality in patients with IPF
by: Shaobo Ge, et al.
Published: (2025-01-01)

Calcified Lung Nodules: A Diagnostic Challenge in Clinical Daily Practice
by: Elisa Baratella, et al.
Published: (2025-03-01)

Benzyl isothiocyanate provokes senolysis by targeting AKT in senescent IPF fibroblasts and reverses persistent pulmonary fibrosis in aged mice
by: Rui Wang, et al.
Published: (2025-05-01)

Beneficial Impact of Vaccination Against SARS-CoV-2 on the Mental Health of IPF Patients
by: Ioannis Tomos, et al.
Published: (2024-11-01)

Therapeutic potential of human stem cell-derived extracellular vesicles in idiopathic pulmonary fibrosis
by: Kyoung Soo Lee, et al.
Published: (2024-12-01)

Optimizing resource allocation in remote healthcare via blockchain-enabled decentralized networks and spectral clustering
by: A. Kanimozhi, et al.
Published: (2025-10-01)

Investigates the Role of PANoptosis in Idiopathic Pulmonary Fibrosis and Potential Therapeutic Targets
by: Xiang Y, et al.
Published: (2024-12-01)

Anti-reflux therapy and mortality in patients with idiopathic pulmonary fibrosis and gastroesophageal reflux disease: a systematic review and meta-analysis
by: Konstantinos Dodos, et al.
Published: (2025-07-01)

Novel Integration of Spatial and Single-Cell Omics Data Sets Enables Deeper Insights into IPF Pathogenesis
by: Fei Wang, et al.
Published: (2025-01-01)

Inhibition of Transglutaminase 2 by a Selective Small Molecule Inhibitor Reduces Fibrosis and Improves Pulmonary Function in a Bleomycin Mouse Model
by: Zhuo Wang, et al.
Published: (2025-03-01)

Mean Platelet Volume-to-Platelet Count Ratio (MPR) in Acute Exacerbations of Idiopathic Pulmonary Fibrosis: A Novel Biomarker for ICU Mortality
by: Maside Ari, et al.
Published: (2025-01-01)

Chest CT in Pulmonary Fibrosis: A Narrative Review of Imaging Patterns and Their Prognostic Significance
by: Mehrshad Dabbagh, et al.
Published: (2025-06-01)